5/21/2014 9:15:30 AM
VANCOUVER, British Columbia, May 21, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical stage pharmaceutical company discovering and developing targeted therapeutics for inflammatory disease and cancer, today announced that David Main, Aquinox's Chief Executive Officer, will present at two upcoming investor conferences.
Help employers find you! Check out all the jobs and post your resume.
comments powered by